Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ICARIIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | ICARIIN |
graph TD
ICARIIN["ICARIIN"]
ICARIIN -->|"inhibits"| Chondrocyte_Ferroptosis["Chondrocyte Ferroptosis"]
ICARIIN -->|"upregulates"| EPHB4["EPHB4"]
ICARIIN -->|"downregulates"| EPHRINB2["EPHRINB2"]
ICARIIN -->|"treats"| Glucocorticoid_Induced_Osteopo["Glucocorticoid-Induced Osteoporosis"]
ICARIIN -->|"treats"| OSTEOPOROSIS["OSTEOPOROSIS"]
ICARIIN -->|"treats"| Osteoarthritis["Osteoarthritis"]
ICARIIN -->|"modulates"| EFNB2["EFNB2"]| Target | Relation | Type | Str |
|---|---|---|---|
| Chondrocyte Ferroptosis | inhibits | process | 0.95 |
| Glucocorticoid-Induced Osteoporosis | treats | disease | 0.90 |
| EPHB4 | upregulates | gene | 0.90 |
| EFNB2 | downregulates | gene | 0.90 |
| Trabecular Bone Density | promotes | phenotype | 0.90 |
| Ros-Mediated Neurodegeneration | protects_against | process | 0.90 |
| Reactive Oxygen Species | inhibits | process | 0.90 |
| EPHRINB2 | downregulates | entity | 0.90 |
| EPHB4 | upregulates | entity | 0.90 |
| OSTEOPOROSIS | treats | entity | 0.85 |
| Parkinson's Disease | treats | disease | 0.85 |
| osteoarthritis | treats | disease | 0.85 |
| Parkinson Disease | treats | disease | 0.85 |
| Osteoarthritis | treats | disease | 0.85 |
| OSTEOCALCIN | upregulates | biomarker | 0.85 |
| RHOA | upregulates | gene | 0.85 |
| malondialdehyde | downregulates | compound | 0.85 |
| OCN | upregulates | protein | 0.80 |
| SOD | upregulates | protein | 0.80 |
| EFNB2 | modulates | gene | 0.80 |
| EPHB4 | modulates | gene | 0.80 |
| HO-1 | upregulates | protein | 0.80 |
| ferroptosis | inhibits | phenotype | 0.72 |
| TNF | regulates | protein | 0.70 |
| Alzheimer's disease | treats | disease | 0.70 |
| ROS | inhibits | phenotype | 0.64 |
| SLC7A11 | activates | gene | 0.64 |
| GPX4 | activates | gene | 0.64 |
| MMP3 | inhibits | gene | 0.56 |
| MMP1 | inhibits | gene | 0.56 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Aseng-Ica | transports | drug | 0.95 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ICARIIN in their description or question text
No additional research found